INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report)’s stock price was up 3.2% on Thursday . The company traded as high as $0.84 and last traded at $0.81. Approximately 25,352 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.79.
INVO Bioscience Stock Performance
The firm’s 50 day moving average is $0.84 and its two-hundred day moving average is $0.82.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. bought a new stake in INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned approximately 2.64% of INVO Bioscience at the end of the most recent quarter. Institutional investors and hedge funds own 12.02% of the company’s stock.
INVO Bioscience Company Profile
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Read More
- Five stocks we like better than INVO Bioscience
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Nebius Group: The Rising Star in AI Infrastructure
- Top Stocks Investing in 5G Technology
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.